serum institute of india
Jump to
126 Results Found
  • Serum Institute’s Poonawalla family refused billion-dollar deal in October 2020 - here is why: Report May 05, 2021 10:24 AM IST

    Serum Institute’s Poonawalla family refused billion-dollar deal in October 2020 - here is why: Report

    In September 2020, the Bill and Melinda Gates Foundation provided $150 million to the Pune-based vaccine-maker to fund the additional 10 crore COVID-19 vaccine doses.

  • COVID-19: Serum Institute to begin Covovax vaccine's phase 3 trial by mid-May May 04, 2021 03:45 PM IST

    COVID-19: Serum Institute to begin Covovax vaccine's phase 3 trial by mid-May

    The ICMR and SII are jointly performing a phase-2/3 observer-blind, randomised, controlled study to determine the safety and efficacy of the Covovax vaccine.

  • Serum Institute of India to invest 240 million pounds in UK: Boris Johnson's Office May 04, 2021 09:38 AM IST

    Serum Institute of India to invest 240 million pounds in UK: Boris Johnson's Office

    The announcement comes a couple of hours ahead of a virtual bilateral summit between Prime Minister Narendra Modi and his British counterpart Boris Johnson. SII is already running phase 1 trials of its new one dose nasal vaccine in the UK, which may be produced in the country once approved.

  • COVID-19 vaccine shortage in India will continue till July, says Serum Institute CEO Adar Poonawalla May 03, 2021 02:11 PM IST

    COVID-19 vaccine shortage in India will continue till July, says Serum Institute CEO Adar Poonawalla

    The Serum Institute has been maligned by politicians and critics over the vaccine shortages, Adar Poonawalla tells Financial Times. "I have been victimised very unfairly and wrongly."

  • COVID-19 Vaccine | Covishield production in full swing: Serum Institute of India CEO Adar Poonawalla May 02, 2021 08:32 AM IST

    COVID-19 Vaccine | Covishield production in full swing: Serum Institute of India CEO Adar Poonawalla

    Serum Institute of India CEO Adar Poonawalla also confirmed that he had “an excellent meeting” with all partners and stakeholders in the United Kingdom.

  • Threats from powerful, head will be chopped off if I comment on elections or Kumbh: SII CEO Adar Poonawalla May 01, 2021 07:32 PM IST

    Threats from powerful, head will be chopped off if I comment on elections or Kumbh: SII CEO Adar Poonawalla

    Serum Institute of India boss Adar Poonawalla in interview to London Times reveals why he is in the UK and talks about the pressure to deliver vaccines in India.

  • PIL filed in Bombay HC seeks sale of vaccines by SII, Bharat Biotech at Rs 150 Apr 28, 2021 01:06 PM IST

    PIL filed in Bombay HC seeks sale of vaccines by SII, Bharat Biotech at Rs 150

    The PIL, filed on April 24 by advocate Fayzan Khan and three law students, said the vaccine is presumed to be an essential commodity and hence its management and distribution cannot be left in the hands of private companies.

  • Covid-19 preparedness: What our chief ministers want from PM Modi Apr 24, 2021 01:50 PM IST

    Covid-19 preparedness: What our chief ministers want from PM Modi

    A look at yesterday's meeting between state chief ministers and Prime Minister Narendra Modi, beyond the television coverage.

  • COVID-19| Karnataka to purchase 1 crore doses of Covishield vaccine at Rs 400 crore Apr 22, 2021 09:20 PM IST

    COVID-19| Karnataka to purchase 1 crore doses of Covishield vaccine at Rs 400 crore

    The Chief Minister gave instructions to strengthen the helpline, aimed at immediately responding to issues faced by the people.

  • BJP MLA slams Serum Institute of India over anti-COVID vaccine pricing, calls its CEO Adar Poonawalla 'dacoit' Apr 22, 2021 05:53 PM IST

    BJP MLA slams Serum Institute of India over anti-COVID vaccine pricing, calls its CEO Adar Poonawalla 'dacoit'

    Gorakhpur MLA Radha Mohan Das Agrawal made the remarks after SII on Wednesday announced a price of Rs 600 per dose for Covishield supplies to private hospitals and Rs 400 per dose to state governments.

  • Adar Poonawalla thanks PM Narendra Modi, FM Sitharaman for 'decisive policy changes, swift financial aid' Apr 20, 2021 02:00 PM IST

    Adar Poonawalla thanks PM Narendra Modi, FM Sitharaman for 'decisive policy changes, swift financial aid'

    Adar Poonawalla's tweet came a day after the Centre approved an advance of around Rs 3,000 crore to the Serum Institute of India. Poonawalla had earlier said that the amount would be needed to ramp up production capacity.

  • Govt gives ‘advance’ of around Rs 4,500 crore to Serum Institute of India, Bharat Biotech Apr 19, 2021 09:19 PM IST

    Govt gives ‘advance’ of around Rs 4,500 crore to Serum Institute of India, Bharat Biotech

    “The Finance Ministry today has relaxed the general financial rules and permitted the Ministry of Health to pay, if they so wish, to make advance payment to vaccine suppliers, without a bank guarantee. I believe the Health Ministry is already doing so,” a top official told Moneycontrol

  • EXCLUSIVE | Diverging views emerge within government on whether to provide financial help to vaccine makers Apr 16, 2021 04:17 PM IST

    EXCLUSIVE | Diverging views emerge within government on whether to provide financial help to vaccine makers

    The difference of opinion has especially widened on whether the dire situation at hand requires the government to provide direct funding to the largest vaccine maker in the world.

  • Help increase COVID-19 vaccine production, lift embargo on raw materials, Adar Poonawalla asks US President Biden Apr 16, 2021 02:34 PM IST

    Help increase COVID-19 vaccine production, lift embargo on raw materials, Adar Poonawalla asks US President Biden

    "I humbly request you to lift the embargo of raw material exports out of the U.S. so that vaccine production can ramp up. Your administration has the details," Poonawalla tweeted.

  • EXCLUSIVE | ‘Government won’t ban commercial export of Covid-19 vaccine’, sources say Apr 12, 2021 11:06 AM IST

    EXCLUSIVE | ‘Government won’t ban commercial export of Covid-19 vaccine’, sources say

    Many have argued for a ban on the commercial export of Covid-19 vaccines from India, as the second wave of the pandemic continues to infect a record number of people every day and vaccine shortages have been reported from multiple States. But the government is not keen on the proposal since both the manufacturers in India are legally obligated to fulfil contracts to supply doses to foreign buyers, and a large chunk of the global poor are dependent on India’s vaccines.

  • COVAX says India's Serum Institute bound to supply virus vaccines Apr 09, 2021 03:46 PM IST

    COVAX says India's Serum Institute bound to supply virus vaccines

    The pact specified Gavi would receive from SII 1.1 billion doses of either the AstraZeneca vaccine or that of Novavax, with 200 million committed, and the rest on option.

  • WHO rejects Serum Institute's proposal seeking extension of Covishield's shelf life from 6 to 9 months Apr 08, 2021 08:18 PM IST

    WHO rejects Serum Institute's proposal seeking extension of Covishield's shelf life from 6 to 9 months

    The WHO has also sought a meeting with Drugs Controller General of India (DCGI) to discuss the matter, sources said.

  • EXCLUSIVE | India's global donations of jabs through 'Vaccine Maitri' on hold for a month, MEA sources say Apr 08, 2021 05:28 PM IST

    EXCLUSIVE | India's global donations of jabs through 'Vaccine Maitri' on hold for a month, MEA sources say

    India has won enormous diplomatic goodwill with free supply of vaccines to poor countries but as daily new cases continue to soar to new record, the government is facing pressure to increase domestic supply and expand the inoculation programme that is so far restricted to people who are at least 45 years old.

  • AstraZeneca has sent Serum Institute a legal notice over delays in COVID-19 vaccine supply: Adar Poonawalla Apr 08, 2021 10:22 AM IST

    AstraZeneca has sent Serum Institute a legal notice over delays in COVID-19 vaccine supply: Adar Poonawalla

    SII will prioritise supplies to India over the next one or two months, Poonawalla has said.

  • India's Serum Institute asks government for $403 million to boost AstraZeneca vaccine output Apr 07, 2021 07:19 PM IST

    India's Serum Institute asks government for $403 million to boost AstraZeneca vaccine output

    About 90 percent of the 86 million doses India has administered since mid-January have come from the Serum Institute of India, with the rest accounted for by a domestic vaccine developed by Bharat Biotech, which is also struggling to boost output.

  • Serum Institute may seek permission for commercial sale of Covishield: Report Apr 05, 2021 09:27 AM IST

    Serum Institute may seek permission for commercial sale of Covishield: Report

    SII might apply for marketing authorisation of the COVID-19 vaccine to the CDSCO by the end of April.

  • EU seeks 10 million AstraZeneca vaccines from India to meet shortfall: Report Apr 01, 2021 07:00 PM IST

    EU seeks 10 million AstraZeneca vaccines from India to meet shortfall: Report

    The EU wants the doses from Serum, the world's largest vaccine maker, to offset supply shortfalls from AstraZeneca's European plants and speed up the bloc's vaccine roll-out.

  • COVID-19 update |Indonesia sees vaccination slowdown as India delays shipments Mar 27, 2021 08:34 PM IST

    COVID-19 update |Indonesia sees vaccination slowdown as India delays shipments

    India has put a temporary hold on all major exports of the AstraZeneca coronavirus shot made by Serum Institute of India (SII), prioritising domestic demand as infections rise.

  • Covax vaccines for poor countries delayed by India: Gavi Mar 25, 2021 06:03 PM IST

    Covax vaccines for poor countries delayed by India: Gavi

    The AstraZeneca-Oxford vaccine is being produced under licence in India for the Covax scheme, also led by the World Health Organization (WHO), which is meant to ensure that low-income countries can access COVID-19 jabs.

  • India delays big exports of AstraZeneca shot as infections surge, sources say Mar 24, 2021 09:13 PM IST

    India delays big exports of AstraZeneca shot as infections surge, sources say

    Indian Prime Minister Narendra Modi's cabinet decided this week to widen its inoculation drive by including everyone above 45 from April 1, and many states battling a surge in infections have demanded that all adults be covered.

Sections